Neonatal Sepsis Clinical Trial
Official title:
Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in Chinese Neonatal Intensive Care Units
Neonatal sepsis remains one of the most important cause of mortality and morbidities in China. This study will establish a prospective registral cohort of all infants with culture-proven neonatal sepsis in Chinese NICUs participating in the Chinese Neonatal Network (CHNN). The microbiology, antimicrobial resistance patterns and neonatal outcomes will be described in detail for this cohort.
Status | Not yet recruiting |
Enrollment | 1200 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Hour to 1 Month |
Eligibility | Inclusion Criteria: - Admitted to CHNN NICUs from 2022.1.1 to 2023.12.31 - Diagnosed with culture-proven sepsis Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital of Fudan University | Chinese Neonatal Network |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall mortality | Incidence of death during the study period | About 3 months from admission to discharge or death | |
Secondary | Sepsis-related mortality (within 7 days of sepsis) | Incidence of death within 7 days after sepsis | About 3 months from admission to discharge or death | |
Secondary | Incidence of multiorgan dysfunction | Propertion of infants who occur multiorgan dysfunction | About 3 months from admission to discharge or death | |
Secondary | Incidence of septic shock | Propertion of infants who occur septic shock | About 3 months from admission to discharge or death | |
Secondary | Incidence of respiratory failure | Propertion of infants who occur respiratory failure | About 3 months from admission to discharge or death | |
Secondary | Incidence of disseminated intravascular coagulation (DIC) | Propertion of infants who occur DIC | About 3 months from admission to discharge or death | |
Secondary | Incidence of renal failure | Propertion of infants who accur renal failure | About 3 months from admission to discharge or death | |
Secondary | Incidence of meningitis | Propertion of infants who accur meningitis | About 3 months from admission to discharge or death | |
Secondary | Incidence of necrotizing enterocolitis | Propertion of infants who accur necrotizing enterocolitis | About 3 months from admission to discharge or death | |
Secondary | Incidence of brain injury | Propertion of infants who accur brain injury | About 3 months from admission to discharge or death | |
Secondary | Length of hospital stay | Days of hospitalization | About 3 months from admission to discharge or death | |
Secondary | Length of antibiotic treatment | Days of antibiotic treatment | About 3 months from admission to discharge or death | |
Secondary | Type and quantity of transfusion | Which kind and how much (ml) of blood product was used during the study | About 3 months from admission to discharge or death |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05692128 -
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
|
||
Completed |
NCT00942084 -
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
|
Phase 1 | |
Completed |
NCT06002295 -
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
|
Phase 2 | |
Not yet recruiting |
NCT05114057 -
Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI
|
N/A | |
Recruiting |
NCT04528251 -
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
|
||
Active, not recruiting |
NCT03871491 -
Azithromycin-Prevention in Labor Use Study (A-PLUS)
|
Phase 3 | |
Completed |
NCT03746743 -
Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II
|
||
Completed |
NCT02386592 -
Prevention of Nosocomial Bacteremia Among Zambian Neonates
|
N/A | |
Not yet recruiting |
NCT06113653 -
Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
|
||
Completed |
NCT03199547 -
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
|
Phase 3 | |
Completed |
NCT02147327 -
Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities
|
N/A | |
Completed |
NCT01005589 -
CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis
|
N/A | |
Completed |
NCT00866567 -
Defects in Opsonophagocytosis in Premature Infants
|
N/A | |
Completed |
NCT02281890 -
Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database
|
N/A | |
Suspended |
NCT05156333 -
Probiotics and GBS Colonization in Pregnancy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Completed |
NCT03755635 -
Neonatal Sepsis at Neonatal Intensive Care Units in Ghana
|
N/A | |
Completed |
NCT03247920 -
Reduction of Intravenous Antibiotics In Neonates
|
Phase 4 | |
Completed |
NCT03295162 -
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
|
Phase 1/Phase 2 | |
Completed |
NCT02954926 -
Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
|
Phase 3 |